logo BDSP

Base documentaire

  1. Endometrial and ovarian cancer and oral contraceptives : findings in a large cohort study.

    Article - En anglais

    Many case-control studies have shown that oral contraceptives protect against endometrial cancer and epithelial ovarian cancer, but little information is available from cohort studies.

    The findings from the Oxford Family Planning Association contraceptive study are reported here ; the relative risks for ever users of oral contraceptives in comparison with never users were 0.1 (95% confidence interval 0.0-0.7) for endometrial cancer and 0.4 (95% confidence interval 0.2-0.8) for ovarian cancer.

    There was a strong negative relationship between duration of oral contraceptive use and ovarian cancer risk.

    Thus, in comparison with never users of oral contraceptives, the relative risk for users of up to 48 months'duration was 1.0 (95% confidence interval 0.4-2.5), while the relative risk for users of 97 months'duration or more was only 0.3 (95% confidence interval 0.1-0.7).

    Mots-clés Pascal : Tumeur maligne, Endomètre, Ovaire, Epidémiologie, Homme, Contraception, Voie orale, Oestroprogestatif, Protection, Etude cohorte, Appareil génital femelle pathologie, Utérus pathologie, Ovaire pathologie

    Mots-clés Pascal anglais : Malignant tumor, Endometrium, Ovary, Epidemiology, Human, Contraception, Oral administration, Estroprogestagen, Protection, Cohort study, Female genital diseases, Uterine diseases, Ovarian diseases

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 95-0378258

    Code Inist : 002B20C02. Création : 01/03/1996.